| Drossapharm AG - Venlax ER 150 mg, Hartkapseln, retardiert | | 59106 | | 03 | | Venlax ER 150 mg | | Hartkapseln, retardiert | | N06AX16 | | Venlafaxin | | 04.06.2009 | | |
| | Composition | | venlafaxinum 150 mg ut venlafaxini hydrochloridum, hypromellosum, ammonio methacrylatis copolymerum B, natrii laurilsulfas corresp. natrium 3.02 mg, magnesii stearas, copolymerum methacrylatis butylati basicum, Kapselhülle: gelatina, E 127, E 132, E 171, pro capsula. | | Packungsbestandteile | | Capsules | | | | | Principe actif | Concentr. |
|---|
| Venlafaxine | 150 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Venlafaxine | 150 mg |
| | | | Agents auxilliaires | | informations additionels |
|---|
| Ammonio Methacrylatis Copolymerum B | | | | Copolymerum Methacrylatis Butylati Basicum | | | | E 127 | | color. | | E 132 | | color. | | E 171 | | color. | | Gelatina | | Kapselhülle | | Hypromellosum | | | | Magnesii Stearas | | | | Natrii Laurilsulfas | | | | Pro Capsula | | |
| |
| |
|
